Results 21 to 30 of about 14,247 (191)
Herpes zoster subunit vaccine for the prevention of herpes zoster
American Journal of Health-System Pharmacy, 2018 Published literature on the efficacy and safety of the herpes zoster (HZ) subunit vaccine (HZ/su vaccine) in reducing the risks of HZ and postherpetic neuralgia (PHN) in adults 50 years of age and older, as well as the vaccine's properties and efficacy relative to live attenuated vaccine, is reviewed.HZ/su vaccine (Shingrix, GlaxoSmithKline) is a ...
Symoniak, Melanie +3 more
openaire +4 more sources
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper
Revista Española de Quimioterapia, 2023 Herpes zoster infection (HZ) is an important public health problem due to its high incidence and frequent complications, especially post-herpetic neuropathy . The incidence of HZ increases with age and is more frequent in immunocompromised patients. It is estimated that at least 60,000 people develop HZ each year in Spain.
Molero García, José María +14 more
openaire +7 more sources
Vacunación frente al virus del herpes zóster
Atención Primaria, 2023 Resumen: Objetivo: Revisar las últimas evidencias publicadas respecto a la vacuna utilizada en nuestro país frente al virus del herpes zóster, desglosadas por eficacia, eficiencia, efectividad y seguridad vacunal.
José Javier Gómez Marco +4 more
doaj +1 more source
Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination [PDF]
Open Forum Infectious Diseases, 2022 Abstract Background The 2-dose recombinant zoster vaccine (RZV) series is recommended for prevention of herpes zoster (HZ) in adults aged ≥50 years, but data are limited on the impact of concomitant administration with other vaccines on subsequent HZ risk.
Katia J Bruxvoort +8 more
openaire +2 more sources
Herpes Zoster Following Covaxin Receipt
International Medical Case Reports Journal, 2021 Oumer Abdu Muhie,1 Haylemariam Adera,1 Eyob Tsige,1 Aschalew Afework2 1Department of Internal Medicine, GAMBY Teaching General Hospital, Bahir Dar, Ethiopia; 2Department of Public Health, GAMBY Teaching General Hospital, Bahir Dar, EthiopiaCorrespondence:
Muhie OA, Adera H, Tsige E, Afework A
doaj
Herpes zoster vaccination. An update
Przegląd Dermatologiczny, 2022 Herpes zoster/shingles is a cutaneous condition caused by the reactivation of varicella zoster virus. The condition mostly occurs when the cell mediated immunity towards varicella zoster virus, which was developed during the varicella zoster virus ...
Khairuddin Djawad +5 more
doaj +1 more source
Awareness and acceptability of herpes zoster vaccination in people living with HIV
Preventive Medicine ReportsObjective: The recombinant herpes zoster vaccine is recommended for aging populations to prevent herpes zoster. We aimed to assess awareness of herpes zoster and acceptance of the herpes zoster vaccine acceptance among people living with HIV (PLWH ...
Christian Motet +3 more
doaj +1 more source
Zhongguo gonggong weishengObjectiveTo systematically evaluate the pharmacoeconomic research on herpes zoster (HZ) vaccine administration, providing reference for related research and prevention of HZ.
Xinping LIU +4 more
doaj +1 more source
The Lancet Public Health, 2018 Background: In 2013, a herpes zoster vaccination programme was introduced in England for adults aged 70 years with a phased catch-up programme for those aged 71–79 years.
Gayatri Amirthalingam, MFPH +6 more
doaj +1 more source
Herpes Zoster in an Immunocompetent Child without a History of Varicella
Pediatric Reports, 2021 Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella−Zoster virus.
Bing-Shiau Shang +2 more
doaj +1 more source